Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Differentiation of Pseudoprogression and True Progression Through High Field Susceptibility Weighted Imaging and R2*

NCT02212964 is registered in ClinicalTrials.gov with Centre for Functional and Metabolic Mapping as lead sponsor.

NCT NCT02212964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02212964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Differentiation of Pseudoprogression and True Progression Through High Field Susceptibility Weighted Imaging and R2*
Lead sponsor
Centre for Functional and Metabolic Mapping
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
March 31, 2016
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

radiation injury, radiation necrosis